DeepNewz, mobile.

People-sourced. AI-powered. Unbiased News.

Screenshot of DeepNewz app showing story detail view.

Screenshot of DeepNewz app showing story list view.

Gilead Sciences News

Gilead, Global Fund Seal Deal to Supply Long-Acting HIV PrEP to 2 Million

Gilead, Global Fund Seal Deal to Supply Long-Acting HIV PrEP to 2 Million

34

5 days ago

Kymera Therapeutics Signs $750 Million Cancer Drug Deal With Gilead Including $85 Million Upfront Amid Sanofi IRAK4 Setback

Kymera Therapeutics Signs $750 Million Cancer Drug Deal With Gilead Including $85 Million Upfront Amid Sanofi IRAK4 Setback

13

1 month ago

Phase 1 Trial Shows mRNA HIV Vaccines Using Membrane-Anchored Trimers Trigger Neutralizing Antibodies Despite Skin Reactions; AIDS Activists Sue HHS Over Gilead Settlement

Phase 1 Trial Shows mRNA HIV Vaccines Using Membrane-Anchored Trimers Trigger Neutralizing Antibodies Despite Skin Reactions; AIDS Activists Sue HHS Over Gilead Settlement

11

1 day ago

Company Earnings

Galapagos Weighs Sale of Cell Therapy Unit After Gilead Waiver

4

9 days ago

Latest stories

Aug 1, 2025
Aug 1, 2025
Law
Bio
Pharma
Phase 1 Trial Shows mRNA HIV Vaccines Using Membrane-Anchored Trimers Trigger Neutralizing Antibodies Despite Skin Reactions; AIDS Activists Sue HHS Over Gilead Settlement
Authors
11
1 day ago
Jul 28, 2025
Jul 28, 2025
Pharma
Science
World
Gilead, Global Fund Seal Deal to Supply Long-Acting HIV PrEP to 2 Million
Authors
34
5 days ago
Jul 24, 2025
Jul 24, 2025
Company Earnings
Bio
Business
Galapagos Weighs Sale of Cell Therapy Unit After Gilead Waiver
Authors
4
9 days ago
Jun 26, 2025
Jun 26, 2025
Pharma
Business
Science
Kymera Therapeutics Signs $750 Million Cancer Drug Deal With Gilead Including $85 Million Upfront Amid Sanofi IRAK4 Setback
Authors
13
1 month ago

Join our channels

Get the latest stories live on any device.

WhatsApp
Top Stories
Join
Telegram
Top Stories
Join